Karuppagounder Vengadeshprabhu, Arumugam Somasundaram, Thandavarayan Rajarajan A, Sreedhar Remya, Giridharan Vijayasree V, Watanabe Kenichi
Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata 956-8603, Japan.
Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata 956-8603, Japan.
Drug Discov Today. 2016 Apr;21(4):632-9. doi: 10.1016/j.drudis.2016.02.011. Epub 2016 Feb 22.
Atopic dermatitis (AD) is an inflammatory skin disease. Over the past few decades, AD has become more prevalent worldwide. Quercetin, a naturally occurring polyphenol, shows antioxidant, anti-inflammatory, and antiallergic activities. Several recent clinical and preclinical findings suggest quercetin as a promising natural treatment for inflammatory skin diseases. Significant progress in elucidating the molecular mechanisms underlying the anti-AD properties of quercetin has been achieved in the recent years. Here, we discuss the use of quercetin as treatment for AD, with a particular focus on the molecular basis of its effect. We also briefly discuss the approaches to improve the bioavailability of quercetin.
特应性皮炎(AD)是一种炎症性皮肤病。在过去几十年中,AD在全球范围内变得更加普遍。槲皮素是一种天然存在的多酚,具有抗氧化、抗炎和抗过敏活性。最近的一些临床和临床前研究结果表明,槲皮素是一种有前景的治疗炎症性皮肤病的天然药物。近年来,在阐明槲皮素抗AD特性的分子机制方面取得了重大进展。在此,我们讨论槲皮素作为AD治疗药物的应用,特别关注其作用的分子基础。我们还简要讨论了提高槲皮素生物利用度的方法。